Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Profit After Tax (2019 - 2025)

Volitionrx (VNRX) has disclosed Profit After Tax for 9 consecutive years, with -$5.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Profit After Tax rose 9.04% year-over-year to -$5.3 million, compared with a TTM value of -$23.0 million through Sep 2025, up 23.75%, and an annual FY2024 reading of -$27.3 million, up 23.6% over the prior year.
  • Profit After Tax was -$5.3 million for Q3 2025 at Volitionrx, up from -$6.3 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $121.8 million in Q2 2021 and bottomed at -$9.6 million in Q2 2023.
  • Average Profit After Tax over 5 years is -$536313.3, with a median of -$7.3 million recorded in 2022.
  • Peak annual rise in Profit After Tax hit 2517.96% in 2021, while the deepest fall reached 34192.53% in 2021.
  • Year by year, Profit After Tax stood at -$8.1 million in 2021, then increased by 9.52% to -$7.3 million in 2022, then fell by 19.95% to -$8.8 million in 2023, then surged by 32.9% to -$5.9 million in 2024, then grew by 10.31% to -$5.3 million in 2025.
  • Business Quant data shows Profit After Tax for VNRX at -$5.3 million in Q3 2025, -$6.3 million in Q2 2025, and -$5.5 million in Q1 2025.